The U.S. Department of Health and Human Services has introduced a new directive called the Policy for Stopping High-Risk Life Sciences Research that will end federal support for work it determines to be “dangerous” gain-of-function research. The policy applies to such research conducted both in the United States and abroad, according to the report.
Officials framed the policy as a tool to halt federal funding for projects that meet the administration’s threshold for high risk. The source did not provide the full text of the policy, the specific criteria that define which experiments will be labeled “dangerous,” or the enforcement procedures HHS will use to implement the change.
The policy changes how federal dollars may be applied to certain life sciences projects. By designating an entire category of work—gain-of-function research—as potentially subject to funding termination, the policy could reshape grantmaking decisions, collaborative research agreements, and the planning of long-term studies that involve manipulation of biological agents.
The announcement comes at a time of significant disruption in the federal research landscape. Between March and June 2025, the National Institutes of Health (NIH) terminated more than 2,500 grants. The source cited that figure but did not elaborate on which grants were affected, the reasons for those terminations, or the institutions and investigators involved.
Unlike some federal research policies that focus solely on domestic activities, HHS’s new policy is reported to cover work conducted both within the United States and overseas. The source did not list the mechanisms HHS will use to oversee or enforce restrictions on foreign-based research receiving U.S. funding, nor did it describe how partner institutions abroad might be notified or held to compliance standards.
Key implementation details were not reported in the source. The article did not include:
Because these specifics were not provided in the source, questions remain about how broadly the policy will be applied and what criteria HHS will use in practice.
The policy emerges amid broader changes in how federal agencies manage research dollars. The source highlighted that the NIH terminated more than 2,500 grants between March and June 2025, a figure presented as part of the wider upheaval in research funding. The article did not supply additional details on the causes of the terminations or on other concurrent federal policy shifts beyond the HHS announcement.
While the precise near-term effects are not detailed in the source, the policy’s stated scope—covering gain-of-function research at home and abroad—suggests possible impacts on grant approvals, ongoing projects that involve altering biological agents, and international collaborations that rely on U.S. support. Institutions and investigators working in related fields may face new review hurdles or funding uncertainty.
The source did not report reactions from academic institutions, industry groups, scientific societies or individual investigators, nor did it include statements from HHS or NIH officials explaining the rationale, enforcement approach, or safeguards for legitimate, lower-risk research.
The source contained no timeline or follow-up actions beyond the announcement of the policy itself. It did not describe whether HHS will publish implementing guidance, convene stakeholder consultations, or issue compliance directives to federal agencies or funding bodies. Absent those details in the source, it is not possible to outline the administrative steps that will follow the policy declaration.
HHS has announced the Policy for Stopping High-Risk Life Sciences Research, which will end federal funding for research it deems “dangerous,” specifically naming gain-of-function research and applying to work in the U.S. and overseas. The change occurs amid significant federal funding turmoil, including NIH’s termination of more than 2,500 grants between March and June 2025. The source did not provide policy text, criteria for designation, enforcement mechanisms, or further implementation details, leaving many operational questions unanswered.
Personalise this feed
Your specialty. Your sources. Your digest.
All set up in under 2 minutes.
Personalise this feed
Your specialty. Your sources. Your digest.
All set up in under 2 minutes.